LeMaitre Vascular, Inc.

$115 ▼ -0.24%

2026-04-21 07:55:00

Explore LeMaitre Vascular, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap

$2.6 B

Current Price

$115

52W High / Low

$118.01 / $78.01

Stock P/E

44.97

Book Value

$17.28

Dividend Yield

0.87%

ROCE

11.72%

ROE

15.8%

Face Value

—

EPS

$2.52

Exp Qtr EPS

—

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

646

Beta

0.67

Debt / Equity

47.16

Current Ratio

12.89

Quick Ratio

11.29

Forward P/E

35.99

Price / Sales

10.46

Enterprise Value

$2.44 B

EV / EBITDA

33.15

EV / Revenue

9.77

Rating

Buy

Target Price

$111.22

EPS Forecast (FY)

—

ABOUT

LeMaitre Vascular, Inc. In essence, is focused on developing, handles the manufacturing of, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. In essence, this organization delivers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. In essence, it delivers a broad range of a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In essence, in addition, This organization delivers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. In essence, it markets its products through a direct sales force and distributors. In essence, this organization was formerly known as Vascutech, Inc. In essence, and changed its name to LeMaitre Vascular, Inc. In April 2001. LeMaitre Vascular, Inc. In essence, was incorporated in 1983 and is headquartered in Burlington, Massachusetts. ROE at 15.80% based on the latest available annual data. ROCE at 11.72% using operating income and capital employed. Debt to equity stands at 0.47x. Operating margin is 21.77% on trailing numbers. Trailing twelve month sales are available in the dataset.

Pros

Healthy return on equity.
Balance sheet leverage appears manageable.
Short-term liquidity looks comfortable.
Strong operating margin profile.
Net margin remains healthy.
Meaningful dividend yield is available.

Cons

Valuation is rich on a P/E basis.

Sift Stocks

S.No.	Name	Price	P.E.	Market Cap	Div Yld %	ROCE	ROE	52Week High/ Low	Book Value
1.	Intuitive Surgical, Inc.	$487.85	62.04	$174.03 B	—	15.96%	16.69%	$603.88 / $427.84	$50.19
2.	Precision Optics Corporation, Inc.	$4.44	—	$47.43 M	—	-40.7%	-73.56%	$6.04 / $3.55	$1.21
3.	Jin Medical International Ltd.	$2.08	13.77	$16.4 M	—	2.06%	4.75%	$19.7 / $1.64	$3.79
4.	Nephros, Inc.	$3.07	27.37	$32.68 M	—	10.54%	12.71%	$6.42 / $1.64	$0.96
5.	Retractable Technologies, Inc.	$0.65	—	$19.46 M	1.18%	-10.73%	-15.56%	$1.14 / $0.62	$2.48
6.	Sanara MedTech Inc.	$20.62	—	$190.4 M	—	16.84%	-1.75%	$35.95 / $16.05	$0.66
7.	AngioDynamics, Inc.	$10.79	—	$449.55 M	—	-11.8%	-17.47%	$13.99 / $8.36	$4.16

Quarterly Results

Figures shown in M / B

	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024
Sales	64.45 M	61.05 M	64.23 M	59.87 M	55.72 M	—
Operating Profit	18.83 M	20.31 M	16.14 M	12.63 M	12.85 M	—
Net Profit	15.58 M	17.36 M	13.78 M	11.01 M	11.18 M	—
EPS in Rs	0.68	0.76	0.6	0.48	0.49	—

Profit & Loss

Figures shown in M / B

	2025	2024	2023	2022
Sales	249.6 M	219.86 M	193.48 M	161.65 M
Operating Profit	67.91 M	52.26 M	37.2 M	29.94 M
Net Profit	57.73 M	44.04 M	30.11 M	20.64 M
EPS in Rs	2.53	1.93	1.32	0.91

Balance Sheet

Figures shown in M / B

	2025	2024	2023	2022
Total Assets	615.69 M	551.82 M	346.78 M	310.48 M
Total Liabilities	222.17 M	214.53 M	48.88 M	42.27 M
Equity	393.52 M	337.29 M	297.9 M	268.2 M
Current Assets	468.23 M	402.19 M	194.6 M	161.73 M
Current Liabilities	36.32 M	30.61 M	29.88 M	25.33 M

Cash Flow

Last available yearly cash flow history

	2025	2024	2023	2022
Operating CF	81.25 M	44.12 M	36.75 M	25.38 M
Investing CF	-64.94 M	-200.12 M	-24.71 M	-10.37 M
Financing CF	-14.54 M	158.1 M	-7.13 M	-9.23 M
Free CF	74.47 M	37.16 M	29.49 M	22.15 M
Capex	-6.78 M	-6.96 M	-7.26 M	-3.23 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

	2024	2023	2022	2021
Revenue Growth %	13.63%	19.69%	—	—
Earnings Growth %	46.28%	45.89%	—	—
Profit Margin %	20.03%	15.56%	12.77%	—
Operating Margin %	23.77%	19.22%	18.52%	—
Gross Margin %	68.63%	65.66%	64.89%	—
EBITDA Margin %	30.33%	25.32%	22.84%	—

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

Ex Date	Dividend
2026-03-12	$0.25
2025-11-20	$0.2
2025-08-21	$0.2
2025-05-15	$0.2
2025-03-13	$0.2
2024-11-21	$0.16
2024-08-15	$0.16
2024-05-15	$0.16
2024-03-13	$0.16
2023-11-15	$0.14
2023-08-16	$0.14
2023-05-16	$0.14
2023-03-08	$0.14
2022-11-16	$0.125
2022-08-24	$0.125
2022-05-16	$0.125
2022-03-07	$0.125
2021-11-18	$0.11
2021-08-25	$0.11
2021-05-18	$0.11

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name	Type	Shares	Value	% Out	Report Date
Professionally Managed Portfolios-Congress Small Cap Growth Fund	Mutual Fund	0.44 M	$47.74 M	0.02%	2026-02-28
iShares Trust-iShares Core S&P Small-Cap ETF	Mutual Fund	1.26 M	$136.39 M	0.06%	2026-01-31
First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers	Mutual Fund	0.91 M	$98.32 M	0.04%	2026-01-31
iShares Trust-iShares Russell 2000 ETF	Mutual Fund	0.49 M	$53.24 M	0.02%	2026-01-31
Nationwide Mutual Funds-Nationwide Geneva Small Cap Growth Fund	Mutual Fund	0.25 M	$27.11 M	0.01%	2026-01-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	Mutual Fund	0.2 M	$21.86 M	0.01%	2026-01-31
Blackrock Inc.	Institutional	3.13 M	$339.82 M	0.14%	2025-12-31
Vanguard Group Inc	Institutional	1.62 M	$175.97 M	0.07%	2025-12-31
Conestoga Capital Advisors, LLC	Institutional	1.42 M	$154.6 M	0.06%	2025-12-31
Conestoga Funds-Conestoga Small Cap Fund	Mutual Fund	0.98 M	$106.79 M	0.04%	2025-12-31
First Trust Advisors LP	Institutional	0.94 M	$102 M	0.04%	2025-12-31
Copeland Capital Management, LLC	Institutional	0.89 M	$96.45 M	0.04%	2025-12-31
Geneva Capital Management LLC	Institutional	0.81 M	$88.38 M	0.04%	2025-12-31
State Street Corporation	Institutional	0.81 M	$87.55 M	0.04%	2025-12-31
Congress Asset Management Co	Institutional	0.73 M	$79.45 M	0.03%	2025-12-31